Loading ...
Sorry, an error occurred while loading the content.

984Plandai Biotechnology to transform the world of nutraceuticals

Expand Messages
  • newsletter@microcapsnewsalert.com
    May 30, 2013
      You are receiving this because you have been subscribed to our website.
      If you no longer wish to receive this newsletter please click this removal link Unsubscribe / Change Profile.

      Plandai Biotechnology ( PLPL )

       

      Good Morning,

      We would like to introduce you to one of our newest clients: Plandai Biotechnology, Inc. (PLPL). Plandai Biotechnology, Inc. (PLPL) is a fully reporting biotechnology company trading on OTC Markets and it's industry classified is Pharmaceuticals preparations.

      Plandaí­ Biotechnology, Inc. (PLPL) intends to transform the world of nutraceuticals by making available extracts from live plant material that deliver the highest levels of bioavailability currently in the market. Plandaí­ Biotechnology, Inc. (PLPL) is the culmination of over ten years of research in the field of plant extracts. Its principle holdings consist of land, farms and infrastructure, totaling more than 8500 acres, in the province of Mpumalanga, South Africa.

       

      About Plandai Biotechnology, Inc. (PLPL)

      Plandaí Biotechnology, Inc. (PLPL) focuses on the farming of whole fruits, vegetables, and live plant material. It produces and sells timber and agricultural products from its farm and tea estate holdings in South Africa. The company also focuses on the production of proprietary functional foods and botanical extracts for the health and wellness industry. It is developing two extracts, including Phytofare green tea catechin extract and Phytofare citrus limonoid glycoside complex. Plandaí Biotechnology, Inc. intends to market its extracts to end users, as well as to nutriceutical and supplement companies. The company is based in Seattle, Washington.

      Products and benefits

      “BIOAVAILABILITY" can be defined as a measurement of the amount of compound absorbed into the bloodstream.

      In the market today, green tea high purity EGCG extracts, with an average selling price of $500/kg, have poor bioavailability of between 1-10%. Plandaí proprietary plant extracts has shown, in published studies, to have increased bioavailability. We believe through our studies that this is between 60-80%, far exceeding anything currently available today.

      The company’s extracts include but are not limited to, gallate catechins from green tea, (catechin gallate (CG),epigallocatechin gallate (EGCG), gallocatechin gallate (GCG), and epicatechin gallate (ECG); carotenoids (lycopene)from tomatoes, as well as citrus bioflavonoids and limonoids. Furthermore, Plandaí's gallate catechin extract will be the active ingredient in formulated products supporting weight loss, anti-aging, the lowering of blood cholesterol, the regulation of high blood pressure and controlling diabetes 1 and 2.

      This means, that Plandaí's extracts deliver a more meaningful and beneficial dose at highly competitive prices to the consumer, in wellness terms

      The Northern American and European natural extracts market are emerging and in a state of intense competition. The shift towards natural ingredients is driving the expansion of the natural extracts market. Among the flurry of ingredients competing in the natural extracts market, green tea extracts is a pioneer and one of the most prominent success stories. (Frost & Sullivan Research, 2011)

      Current Project

      Senteeko Estate

      Plandaí Biotechnology, Inc., through its wholly owned subsidiaries, farms over 7500 acres of luscious land in the Mpumalanga province of South Africa.

      It farms a whole fruit basket of produce which it uses in its creation of highly bioavailable extracts, ranging from citrus to avocado pears to most notably over 2000 acres of tea.

      The tea plant, Camellia Sinensis, is an evergreen shrub or tree and can grow to heights of 30ft though for cultivation is pruned to heights of 2-5ft.

      Farming in South Africa is like no other country in the world and because of this we needed to make sure that we stacked the deck in our favour and employed only the best as ever y step of the product creation pathway is critical. With that in mind, our farming team has over 100 years of experience in managing farms in Southern Africa.

      Recent News

      May 28, 2013

      Plandai Biotechnology, Inc.'s Tomato Based Product Offers Benefits for Certain Cancers

      Plandaí Biotechnology, Inc.'s (OTCQB: PLPL) Phytofare™ brand will feature three botanical extracts with a much higher bioavailability than the current market offers. In a three-part series covering each of the new products, Stock Market Media Group, a full service research and content development investor relations firm, has covered the green tea based Phytofare™ Catechin Extract and the company's citrus based Phytofare™ Limonoid Glycoside Complex. To read the full release, click here.

       
      © Microcap News Alerts. Contact us at contact@...
                                                                                                                             
      Please read this disclaimer in full.
      This report/release/advertisement is a commercial advertisement and is for general information and marketing purposes only. We are engaged in the business of marketing and advertising companies for compensation (monetary and/or equity). Never invest in any company stock featured on our site or emails unless you can afford to lose your entire investment. You should always consult with a financial professional before making any investment. The disclaimer is to be read and fully understood before using our website, or joining our email list. Full disclaimer can be read at one our website: http://www.microcapnewsalerts.com/disclaimer/
      MicroCapNewsAlerts.com (or its affiliate) has been compensated directly from a third party non affiliate in the amount of two thousand five hundred dollars for advertising services regarding Plandai Biotechnology, Inc. (PLPL) for a thirty day period.  Such services include but are not limited to the preparation and publication of this profile, and social media coverage. MicroCapNewsAlerts.com receives the compensation amount as a production budget and it will retain as its fee for services rendered any and all amounts which exceed its actual costs of production, copy writing, and e-mailing and other distribution expenses. MicroCapNewsAlerts.com has not directly or through third parties investigated Plandai Biotechnology, Inc. (PLPL) or its business, management, or control persons. Plandai Biotechnology, Inc. (PLPL) provided and approved all of the content contained in this email as well as the information contained on the hyperlinks. Accordingly, our profile of Plandai Biotechnology, Inc. is, and it should be read, ONLY, as a paid advertisement which is neither unbiased nor independent, and you should consider this disclaimer when evaluating the contents of this profile.
       
      Release of Liability: Through use of this website or email viewing you agree to hold MicroCapNewsAlerts.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data.
      Third Party Website and Information: This site and email you receive may provide hyperlinks to third party websites or access to third party content. MicroCapNewsAlerts.com does not control, endorse, or guarantee content found in such sites. You agree that MicroCapNewsAlerts.com is not responsible for any content, associated links, resources, or services associated with a third party site. You further agree that MicroCapNewsAlerts.com shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only.
      MicroCapNewsAlerts.com encourages its readers to supplement this profile with independent research and professional financial advice. Our newsletter has relied upon information supplied by its customers, press releases, and other publicly available information which assumes is accurate in all material respects; however, such accuracy cannot be guaranteed.  This advertisement does not constitute offers or solicitations to purchase or sell securities of the company profiled herein, and any decision to invest in any such company or other financial decisions should not be made based upon the content of this advertisement.  Instead we strongly urge you conduct a complete and independent investigation of the company and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D, www.otcmarkets.com, www.sec.gov, www.finra.org, and www.investor.gov.
       
      Investing or trading in development stage micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. An entire investment may be lost or impaired due to the highly speculative nature of the company profiled.
      MicroCapNewsAlerts.com is an electronic publication, and it is published for informational purposes only. We do not undertake or purport to render investment advice or recommendations or solicitations for the buying and selling of securities. We are not, and we do not hold ourselves out to be, a registered broker or dealer or investment advisor or other licensed professional engaged in any jurisdiction in the securities, money management or investment business or any aspect thereof. Our website and our free and subscription-based newsletters are not a solicitation to buy or sell securities. Investing or trading in development stage micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. An entire investment may be lost or impaired due to the highly speculative nature of the company profiled.
       
      MicroCapNewsAlerts.com is owned by: Jakt, LLC, Inc. 366 N. Broadway Suite 410 Jericho, New York 11753
      Questions regarding this email advertising may be sent to Info@...
            
      Best Wishes, 
       
      Ja Spa and Fitness staff
       
      16 Main Street
      Marcellus, NY 13108
      Contact No : (315) 673-9341
      Email: events@...